PDCD1 and cancer: ICIs can reinvigorate exhausted T (Tex) cells, but the effect is not sustainable [86], and in one study, only ~10% Tex cells fully responded to PD-1 blockade; [87] these results partly explain the failure of ICIs in patients with refractory cancer.